C₂₆H₂₉NO (P274)
Quantities
| P4250 | defined daily dose | 20 |
| P2067 | mass | 371.225 |
| P3780 | active ingredient in | ... | Q47522138 (Soltamox) | Soltamox |
| P233 | canonical SMILES | String | CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3 | ??? |
| P373 | Commons category | String | Tamoxifen | ??? |
| P703 | found in taxon | ... | Q104838133 (Streptomyces nigra) | Streptomyces nigra |
| P703 | found in taxon | ... | Q6719593 (Aspergillus sclerotiorum) | Aspergillus sclerotiorum |
| P527 | has part(s) | ... | Q556 (hydrogen) | hydrogen |
| P527 | has part(s) | ... | Q623 (carbon) | carbon |
| P527 | has part(s) | ... | Q629 (oxygen) | oxygen |
| P527 | has part(s) | ... | Q627 (nitrogen) | nitrogen |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CC/C(=C(\C1=CC=CC=C1)/C2=CC=C(C=C2)OCCN(C)C)/C3=CC=CC=C3 | ??? |
| P1987 | MCN code | String | 2922.19.95 | ??? |
| P1987 | MCN code | String | 3003.90.44 | ??? |
| P2175 | medical condition treated | ... | Q128581 (breast cancer) | breast cancer |
| P2175 | medical condition treated | ... | Q212961 (pancreatic cancer) | pancreatic cancer |
| P2175 | medical condition treated | ... | Q18554119 (infant gynecomastia) | infant gynecomastia |
| P5008 | on focus list of Wikimedia project | ... | Q132578991 (???) | ??? |
| P129 | physically interacts with | ... | Q5401857 (estrogen receptor 2) | estrogen receptor 2 |
| P129 | physically interacts with | ... | Q5401858 (estrogen receptor 1) | estrogen receptor 1 |
| P129 | physically interacts with | ... | Q5514257 (G protein-coupled estrogen receptor 1) | G protein-coupled estrogen receptor 1 |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P3489 | pregnancy category | ... | Q3679234 (Australian pregnancy category B3) | Australian pregnancy category B3 |
| P769 | significant drug interaction | ... | Q304088 (acenocoumarol) | acenocoumarol |
| P769 | significant drug interaction | ... | Q422244 (fluoxetine) | fluoxetine |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P279 | subclass of | ... | Q27164528 (2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine) | 2-[4-(1,2-diphenylbut-1-enyl)phenoxy]-N,N-dimethylethanamine |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q50429983 (estrogen antagonist) | estrogen antagonist |
| P2868 | subject has role | ... | Q50430266 (hormonal antineoplastic agent) | hormonal antineoplastic agent |
| P2868 | subject has role | ... | Q50430327 (bone density conservation agents) | bone density conservation agents |
| P2868 | subject has role | ... | Q903917 (selective estrogen-receptor modulators) | selective estrogen-receptor modulators |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | tamoxifen | ??? |
Why not click here or view trends?
log id: None